FDA orders drugmaker to stop selling opioid painkiller

Endo Pharmaceuticals received an FDA warning on Thursday to remove Opana ER from the market. It is the first time US regulators have asked for a firm to discontinue an opioid painkiller.

Source: the Mail online | Health - June 8, 2017 Category: Consumer Health News Source Type: news